← brief for 2026-09-12 · Slowing decline

SGK2 Promotes NEDD4L-Mediated ACSL4 Ubiquitination to Inhibit Ferroptosis and Alleviate Diabetic Kidney Disease.

Key takeaways

Even with today's best diabetes drugs, kidney tubules keep getting damaged, and one cause is a form of cell death driven by iron (ferroptosis). This study found that an enzyme called SGK2 tags a key ferroptosis protein for disposal, which shuts that cell death down and eases kidney damage from diabetes. The work was done in animals and cells, not in people. It points at a possible drug target, nothing more for now.

Who did this work

Zhang F · Zhang AD · Wang LW · Liao GY · Zhang M · Ge YT · Liu XR

Source

Article · PubMed, the drug frontier · 2026 Sep 12
https://pubmed.ncbi.nlm.nih.gov/42730475/